A clinical study comparing the effects of chemotherapy plus Avastin to chemotherapy plus Avastin plus a new drug (MEGF0444A) in patients with colorectal cancer that has spread to other parts of the bo...

Update Il y a 4 ans
Reference: EUCTR2011-001867-28

A clinical study comparing the effects of chemotherapy plus Avastin to chemotherapy plus Avastin plus a new drug (MEGF0444A) in patients with colorectal cancer that has spread to other parts of the body, who have not received chemotherapy before

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To estimate the efficacy of MEGF0444A used in combination with FOLFOX + bevacizumab therapy in patients with previously untreated mCRC, as measured by progression-free survival (PFS)


Inclusion criteria

  • PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL CANCER